(Q53397948)

English

Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (MO) disease

scientific article published on November 15, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (MO) disease (English)

reason for preferred rank

most precise value

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

1 reference

based on heuristic

inferred from title

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Florent de Vathaire

5

object named as

F. de Vathaire

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

author name string

de Vathaire F

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

G. Recondo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

E. Cvitkovic

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

N. Azli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

E. Tellez Bernal

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

P. Wibault

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

J. M. Richard

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

P. Marandas

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

M. Benahmed

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

C. Domenge

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1717121

7 November 2022

language of work or name

0 references

publication date

1 November 1991

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

15 November 1991

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1717121

7 November 2022

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

68

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

2109-2119

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819911115%2968%3A10%3C2109%3A%3AAID-CNCR2820681004%3E3.0.CO%3B2-M

21 January 2018

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819911115%2968%3A10%3C2109%3A%3AAID-CNCR2820681004%3E3.0.CO%3B2-M

21 January 2018

Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: Tentative multivariate modelling system to predict the radiocurability of neck nodes

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819911115%2968%3A10%3C2109%3A%3AAID-CNCR2820681004%3E3.0.CO%3B2-M

21 January 2018

Radiation therapy alone or in combination with surgery in head and neck cancer

2

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Distant metastases from head and neck cancer

3

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin. A phase I-II study

5

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Cancer Treatment Reports

6

61

1533

author name string

Wittes

publication date

1977

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Chemotherapeutic management of head and neck cancer

7

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck

8

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck

9

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin

10

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer

12

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck

13

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Cancer Treatment Reports

14

62

2011

author name string

Sikic

publication date

1978

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion

15

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion

16

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Predictive factors for tumor response to preoperative chemotherapy in patients with head and neck squamous carcinoma: The head and neck contracts program

17

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Induction therapy in head and neck cancer. A comparison of two regimens

18

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

20

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin

22

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Phase II Study of Cisplatin and Continuous-Infusion 5-Fluorouracil and Bleomycin for Recurrent and Metastatic Head and Neck Squamous-Cell Carcinoma

24

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Les Annales d'oto-laryngologie

29

102

1

author name string

Laccourreye

publication date

1985

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer

31

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Proceedings of the American Association for Cancer Research

34

27

185

author name string

Haas

publication date

1986

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Carboplatin and continuous infusion 5-fluorouracil for advanced head and neck cancer

35

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer

38

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck

39

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Prognostic factors for loco/regional control and metastasis and the impact on survival

41

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer

44

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study

45

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study

46

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study

47

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Computed Tomographic Density of Metastatic Lymph Nodes as a Treatment-Related Prognostic Factor in Advanced Head and Neck Cancer

49

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Proceedings of the American Association for Cancer Research

50

31

170

author name string

Cvitkovic

publication date

1990

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Proceedings of the American Association for Cancer Research

51

29

27

author name string

Ensley

publication date

1988

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

A favorable subset of AJCC stage IV squamous cell carcinoma of the head and neck

52

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging

54

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy

56

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis

57

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck

58

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial

60

1 reference

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(19911115)68:10%3C2109::AID-CNCR2820681004%3E3.0.CO;2-M

7 November 2022

Identifiers

10.1002/1097-0142(19911115)68:10<2109::AID-CNCR2820681004>3.0.CO;2-M

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/1717121

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53397948&oldid=1766320346"